REGENERON PHARMACEUTICALS, INC. (REGN) — Q1 2026 13F-HR

← REGENERON PHARMACEUTICALS, INC. (REGN)

Q1 2026 · 13F-HR

REGENERON PHARMACEUTICALS, INC. (REGN)holdings as filed

Filed 2026-05-08 · accession 0001104659-26-057922

$47.9M

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · REGENERON PHARMACEUTICALS, INC. (REGN) · Q1 2026

AI · grounded in 13F

REGENERON PHARMACEUTICALS, INC. (REGN) reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
45826J105	NTLA	Intellia Therapeutics, Inc.	$47.5M	99.1%	3,702,995	Common	SOLE
007002108	TORCEUR	Adicet Bio, Inc.	$412,080	0.86%	60,511	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.